Centessa Pharmaceuticals-adr Share Price Today
(NASDAQ: CNTA)

Name: Centessa Pharmaceuticals-adr Share Price Today (NASDAQ: CNTA) - Centessa Pharmaceuticals-adr Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Centessa Pharmaceuticals-adr share price is $16.96 & ₹1,474.99 as on 6 Mar 2025, 2.30 'hrs' IST

$16.96

▲

0.63

(3.86%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Centessa Pharmaceuticals-adr share price in Dollar and Rupees. Guide to invest in Centessa Pharmaceuticals-adr stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Centessa Pharmaceuticals-adr, along with analyst recommendations, forecasts, and comprehensive financials.

Centessa Pharmaceuticals-adr share price movements

Today's Low: $16.11
Today's High: $17.08
$16.96
5.01%
Downside
Day's Volatility :5.65%
Upside
0.67%
52 Weeks Low: $7.75
52 Weeks High: $19.09
$16.96
54.3%
Downside
52 Weeks Volatility :59.4%
Upside
11.16%

Centessa Pharmaceuticals-adr (CNTA) Returns

Period	Centessa Pharmaceuticals-adr	Sector (Health Care)	Index (Russel 2000)
3 Months	-3.03%	3.7%	0.0%
6 Months	16.16%	-2.8%	0.0%
1 Year	53.76%	2.5%	0.0%
3 Years	127.65%	12.9%	-11.6%

Centessa Pharmaceuticals-adr (CNTA) Key Statistics

in dollars & INR

Previous Close	$16.33
Open	$16.49
Today's High	$17.075
Today's Low	$16.11
Market Capitalization	$2.2B
Today's Volume	$1.0M
52 Week High	$19.09
52 Week Low	$7.75
Revenue TTM	$6.9M
EBITDA	$-161.3M
Earnings Per Share (EPS)	$-1.65
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-42.52%

How to invest in Centessa Pharmaceuticals-adr Stock (CNTA) from India?

It is very easy for Indian residents to invest directly in Centessa Pharmaceuticals-adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Centessa Pharmaceuticals-adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Centessa Pharmaceuticals-adr or CNTA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Centessa Pharmaceuticals-adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Centessa Pharmaceuticals-adr shares which would translate to 0.051 fractional shares of Centessa Pharmaceuticals-adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Centessa Pharmaceuticals-adr, in just a few clicks!

Returns in Centessa Pharmaceuticals-adr (CNTA) for Indian investors in Rupees

The Centessa Pharmaceuticals-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Centessa Pharmaceuticals-adr investment value today

Current value as on today

₹1,58,711

Returns

₹58,711

(+58.71%)

Returns from Centessa Pharmaceuticals-adr Stock

₹53,762 (+53.76%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Centessa Pharmaceuticals-adr (CNTA)

-8%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Centessa Pharmaceuticals-adr Stock from India on INDmoney has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Centessa Pharmaceuticals-adr

Medicxi Ventures Management (Jersey) Ltd
15.14%
General Atlantic Llc
7.34%
Perceptive Advisors LLC
4.82%
First Light Asset Management, LLC
4.40%
T. Rowe Price Associates, Inc.
4.07%
Adage Capital Partners Gp LLC
3.88%

Analyst Recommendation on Centessa Pharmaceuticals-adr

Buy

81%Buy

18%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Centessa Pharmaceuticals-adr(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Centessa Pharmaceuticals-adr Stock (CNTA)

What analysts predicted

Upside of 68.46%

Target:

$28.57

Current:

$16.96

Insights on Centessa Pharmaceuticals-adr Stock (Ticker Symbol: CNTA)

Price Movement
In the last 7 days, CNTA stock has moved up by 12.6%
CNTA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 12.7%
Price to Sales
ForCNTA every $1 of sales, investors are willing to pay $260.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Centessa Pharmaceuticals-adr Technicals Summary

Sell

Neutral

Buy

Centessa Pharmaceuticals-adr is currently in a neutral trading position according to technical analysis indicators.

Centessa Pharmaceuticals-adr (CNTA) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Centessa Pharmaceuticals-adr	3.35%	16.16%	53.76%	127.65%	-22.66%
Regeneron Pharmaceuticals, Inc.	-1.42%	-40.28%	-29.31%	11.08%	44.83%
Beone Medicines Ltd	17.63%	36.87%	64.37%	45.89%	71.3%
Vertex Pharmaceuticals Incorporated	1.94%	4.92%	19.37%	108.73%	123.83%
Alnylam Pharmaceuticals, Inc.	-8.03%	-0.89%	66.53%	52.9%	126.66%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Centessa Pharmaceuticals-adr	NA	NA	NA	-1.43	-0.43	-0.2	NA	3.79
Regeneron Pharmaceuticals, Inc.	17.86	17.86	1.01	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Centessa Pharmaceuticals-adr	Buy	$2.2B	-22.66%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$73.8B	44.83%	17.86	31.07%
Beone Medicines Ltd	NA	$29.1B	71.3%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.9B	123.83%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	126.66%	NA	-12.37%

About Centessa Pharmaceuticals-adr

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines for patients. Its products pipeline includes SerpinPC, an activated protein C inhibitor for the treatment of hemophilia A and B; and ORX750, an orally administered OX2R agonist for the treatment of narcolepsy and other sleep disorders. The company also develops LB101, a PD-L1xCD47 LockBody, a bi-specific monoclonal antibody for solid tumors, which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; and OX2R Agonists compounds are currently in development for the treatment of narcolepsy. In addition, its products pipeline comprises ORX750, an orally administered selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and earlier-stage preclinical assets and discovery-stage programs. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

Organization	Centessa Pharmaceuticals-adr
Employees	75
CEO	Dr. Saurabh Saha M.D., Ph.D.
Industry	Healthcare

Management People of Centessa Pharmaceuticals-adr

Name	Title
Dr. Saurabh Saha M.D., Ph.D.	CEO & Director
Dr. David M. Chao Ph.D.	Chief Administrative Officer
Mr. John J. Crowley CPA	CFO and Principal Financial & Accounting Officer
Ms. Tia L. Bush	Chief Technology & Quality Officer
Ms. Kristen K. Sheppard Esq., J.D.	Senior Vice President of Investor Relations & Corporate Communications
Mr. Iqbal J. Hussain L.L.B.	General Counsel, Chief Compliance Officer & Corporate Secretary
Ms. Karen M. Anderson	Chief People Officer
Dr. Gregory M. Weinhoff M.B.A., M.D.	Chief Business Officer
Dr. Mario Alberto Accardi Ph.D.	President of the Orexin Program
Dr. Ellie Im M.D.	Senior Vice President of Clinical Development & Oncology

Important FAQs about investing in CNTA Stock from India :

What is Centessa Pharmaceuticals-adr share price today?

Centessa Pharmaceuticals-adr share price today stands at $16.96, Open: $16.49 ; Previous Close: $16.33 ; High: $17.08 ; Low: $16.11 ; 52 Week High: $19.09 ; 52 Week Low: $7.75.

The stock opens at $16.49, after a previous close of $16.33. The stock reached a daily high of $17.08 and a low of $16.11, with a 52-week high of $19.09 and a 52-week low of $7.75.

Can Indians buy Centessa Pharmaceuticals-adr shares?

Yes, Indians can invest in the Centessa Pharmaceuticals-adr (CNTA) from India.

With INDmoney, you can buy Centessa Pharmaceuticals-adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Centessa Pharmaceuticals-adr at zero transaction cost.

How can I buy Centessa Pharmaceuticals-adr shares from India?

It is very easy to buy Centessa Pharmaceuticals-adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Centessa Pharmaceuticals-adr (CNTA) be purchased?

Yes, you can buy fractional shares of Centessa Pharmaceuticals-adr with INDmoney app.

What are the documents required to start investing in Centessa Pharmaceuticals-adr stocks?

To start investing in Centessa Pharmaceuticals-adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.